Latest Mankind Pharma stock price

Mankind Pharma P/E Ratio

MANKIND • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
52.17
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 52.17
Current Price ₹2200.80
EPS (TTM) ₹49.28
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 35.92
Historical Range 32.98 - 38.87
Percentile 100.0%

Sector Context

Sector Average 53.41
Sector Median 30.38
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹49.51
Sept 2025 ₹12.39
Mar 2025 ₹10.19

Key P/E Ratio Insights for Mankind Pharma

  • Stock appears overvalued with PE of 52.17, suggesting caution for new investments
  • Current PE is 45.2% above historical average

View the MANKIND equity price for detailed stock performance.

P/E Ratio Historical Trend for Mankind Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 38.87 50.92 ₹1979.20 NSE High
2023 32.98 43.12 ₹1422.30 NSE High

Sector P/E Ratio Comparison

Comparing Mankind Pharma with other companies in Healthcare sector
Sector Average
53.41
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low